跳至主要内容
临床试验/NCT02963298
NCT02963298已完成不适用

Pilot Trial Concerning Glutamate Elimination With CRRT for Neurological Outcome After Cardiac Arrest

C. Storm2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2016年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
试验地点
2
主要终点
Glutamate blood concentration in intervention arm over the time

研究概览

简要总结

Glutamate is known to be a mediator for apoptosis after brain hypoxia e.g. due to cardiac arrest. This pilot trial evaluates the possibility of elimination of Glutamate by CRRT after cardiac arrest.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • post cardiac arrest

排除标准

  • hemodynamic instable
  • in-hospital cardiac arrest

研究组 & 干预措施

CRRT after cardiac arrest

Active Comparator

Continuous renal replacement therapy (CRRT) after cardiac arrest for 72 hours for elimination of Glutamate. Repetitive testing of blood Glutamate levels.

干预措施: Continuous renal replacement therapy (Procedure)

control

No Intervention

Repetitive testing of blood Glutamate levels without CRRT

结局指标

主要结局

Glutamate blood concentration in intervention arm over the time

时间窗: 72 hours

Reduction of blood Glutamate concentration by renal replacement therapy

次要结局

  • number of participants with abnormal outcome parameters(up to 14 days)

研究者

发起方
C. Storm
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

C. Storm

PD Dr. med.

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验